China Targets U.S. Biotech Firm in Broadening Blacklist

China escalated its trade dispute with President Trump by banning Illumina, a top American biotechnology company, from importing gene-mapping products. Beijing also targeted other US companies, including Skydio, with punitive measures, adding some to an “unreliable entities list.” This move marks a shift in China’s retaliatory tactics and may signal further actions against American businesses in China, impacting trade relations between the two countries.

Full Article